grant
Disease Mechanisms of Early Pulmonary Fibrosis
Organization UNIVERSITY OF MICHIGAN AT ANN ARBORLocation ANN ARBOR, UNITED STATESPosted 17 Sept 2024Deadline 31 Jul 2029
NIHUS FederalResearch GrantFY2025Airway failureAtlasesAutomobile DrivingBiologicalBiological MarkersBiopsyBloodBlood Reticuloendothelial SystemBody TissuesBronchioalveolar LavageBronchoalveolar LavageBronchopulmonary LavageCausalityCell BodyCellsCessation of lifeChemicalsCicatrixClinicalCohort StudiesConcurrent StudiesDataDeathDevelopmentDiseaseDisease ProgressionDisorderDistalDysfunctionEarly identificationEnvironmentEnvironmental ExposureEnvironmental ToxinEpigeneticEpigenetic ChangeEpigenetic MechanismEpigenetic ProcessEpigenetic ageEpitheliumEtiologyEvaluationEventFunctional disorderFutureGasesGene TranscriptionGeneticGenetic DiversityGenetic PredispositionGenetic Predisposition to DiseaseGenetic RiskGenetic SusceptibilityGenetic TranscriptionGenetic VariationGenetic propensityGenomicsGoalsImageIn SituInherited PredispositionInherited SusceptibilityInjuryInterventionKnowledgeLengthLungLung Alveolar EpitheliaLung LavageLung Respiratory SystemLung Tissue FibrosisMeasuresMediatingMetabolicMetalsModelingMolecularMorbidityMorbidity - disease rateMotionNatural HistoryNatureOrganoidsPathogenesisPatientsPhenotypePhysiopathologyPreventionPulmonary FibrosisQTLQuantitative Trait LociRNA ExpressionRelative RisksRespiratory EpitheliumRespiratory FailureRiskRisk-associated variantScarsServicesShapesStandardizationStimulusStructure of respiratory epitheliumSymptomsTechnologyTestingTherapeuticTimeTissuesToxic Environmental AgentsToxic Environmental SubstancesTranscriptionWorkairway epitheliumalveolar epitheliumbio-markersbiologicbiologic markerbiomarkerbronchiolar alveolar lavagebronchopulmonary lavage therapycausationcell typecohortdata acquisitiondata acquisitionsdevelopmentaldisease causationdisease modeldisease preventiondisorder modeldisorder preventiondrivingenvironmental toxicantepigeneticallyepithelial injuryepithelial repairexposomefibrosis in the lungfunctional genomicsgenetic etiologygenetic mechanism of diseasegenetic vulnerabilitygenetically predisposedhuman subjectimagingimprovedinjuriesinjury responseinsightinterstitiallung fibrosismortalitymultiomicsmultiple omicsnew approachesnovelnovel approachesnovel strategiesnovel strategypanomicspathophysiologypre-clinicalpreclinicalpreventpreventingprogramsrepairrepairedrespiratory tract epitheliumresponseresponse to injuryrisk allelerisk generisk genotyperisk locirisk locusrisk stratificationrisk variantspatial RNA sequencingspatial gene expression analysisspatial gene expression profilingspatial resolved transcriptome sequencingspatial transcriptome analysisspatial transcriptome profilingspatial transcriptome sequencingspatial transcriptomicsspatially resolved transcriptomicsspatio transcriptomicsstratify risktelomeretranscriptome profilingtranscriptomic profilingtranscriptomicstreatment strategy
Description preview
PROGRAM PROJECT SUMMARY
To develop novel, transformative therapies that substantially reduce the burden of morbidity and mortality from
progressive pulmonary fibrosis (PF), a fundamentally new conceptualization of PF is required. It is becoming
clear that lung fibrosis is a consequence, rather than the primary driver, of disease pathobiology and…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click